Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Inhalation for Myocardial Ischemia in CAD
NCT00014040Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 2001
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in Myocardial ischemia (MI), coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Apr 2001; status: completed.
02
Drugs
nitric oxide
03
Conditions
Myocardial ischemia (MI)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00014040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014040.